REFERENCES
- Engström S., Engström L. Phase Behaviour of the Lidocaine-Monoolein-Water System. Int. J. Pharm. 1992; 79: 113–122
- Geraghty P. B., Attwood D., Collett J. H., Dandiker Y. The In Vitro Release of Some Antimuscarinic Drugs from Monoolein/Water Lyotropic Liquid Crystalline Gels. Pharm. Res. 1996; 8: 1265–1271
- Hyde S. T., Ericsson B., Anderson S., Larsson K. A Cubic Structure Consisting of a Lipid Bilayer Forming an Infinite Periodic Minimum Surface of the Gyroid Type in the Glycerylmonooleate-Water System. Z. Kristallogr. 1984; 168: 213–219
- Larsson K. Cubic Lipid-Water Phases. Structures and Biomembrane Aspects. J. Phys. Chem. 1989; 93: 7304–7314
- Hansen J., Nielsen L. S., Norling T. Use of Fatty Acid Esters as Bioadhesive Substances. International patent application PCT/DK95/00143, October 12, 1995, under No. Wo 95/26715
- Engström S., Ljusberg-Wahren H., Gustafsson A. Bioadhesive Properties of the Monoolein Water System. Pharm. Technol. Eur. 1995; 14–17, February
- Geraghty P. B., Attwood D., Collett J. H., Sharma H., Dandiker Y. An Investigation of the Parameters Influencing the Bioadhesive Properties of Myverol 18-99/Water Gels. Biomaterials 1997; 18: 63–67
- Nielsen L. S., Schubert L., Hansen J. Bioadhesive Drug Delivery Systems. I. Characterisation of Mucoadhesive Properties of Systems Based on Glyceryl Mono-oleate and Glyceryl Monolinoleate. Eur. J. Pharm. Sci. 1998; 6: 231–239
- Wallin R., Arnebrant T. The Activity of Lipase at the Cubic Liquid-Crystalline Phase/Water Interface. J. Colloid Interface Sci. 1994; 164: 16–20
- Engström S. Drug Delivery from Cubic and Other Lipid-Water Phases. Lipid Technol. 1990; 2: 42–45
- Wyatt D. M., Dorschel D. A Cubic-Phase Delivery System Composed of Glyceryl Monooleate and Water for Sustained Release of Water-Soluble Drugs. Pharm. Technol. 1992; 16: 116–130
- Nielsen L. S., Hansen J. A Pharmaceutical Composition for Administration of an Active Substance to or Through Skin Mucosal Surface. International patent application PCT/DK96/00437, April 17, 1997, under No. WO 97/13528
- Collett J. H., Attwood D., Burrows R. The Release of Drugs with Low Aqueous Solubility from Liquid Crystalline Phases. Int. Symp. Controlled Release Bioact. Mater. 1990; 17: 283–284
- Engström S., Larsson K., Lindman B. Liquid Crystalline Phases as Delivery Systems for Drugs. Basic Principles. Proc. Int. Symp. Controlled Release Bioact. Mater. 1988; 15: 105–106
- O'Brian J. J., Campoli-Richards D. M. Acyclovir: An Updated Review of Its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy. Drugs 1989; 37: 233–309
- Meadows K. C., Dressman J. B. Mechanism of Acyclovir Uptake in Rat Jejunum. Pharm. Res. 1990; 7: 299–303
- Freeman D. J., Sheth N. V., Spruance L. Failure of Topical Acyclovir in Ointment to Penetrate Human Skin. Antimicrob. Agents Chemother. 1986; 730–732
- Engström S., Lindahl L., Wallin R., Engblom J. A Study of Polar Lipid Drug Carrier Systems Undergoing a Thermoreversible Lamellar-to-Cubic Phase Transition. Int. J. Pharm. 1992; 86: 137–145
- Haigh J. M., Smith E. W. The Selection and Use of Natural and Synthetic Membranes for In Vitro Diffusion Experiments. Eur. J. Pharm. Sci. 1994; 2: 311–330
- Chattaraj S. C., Kanfer I. Release of Acyclovir from Semi-solid Dosage Forms: A Semi-automated Procedure Using a Simple Plexiglas Flow-Through Cell. Int. J. Pharm. 1995; 125: 215–222
- Kristl A., Mrhar A., Kozjek F., Kobe J. Lipophilicity of Guanine Derivatives. Int. J. Pharm. 1989; 57: 229–234
- Higuchi T. Rate of Release of Medicaments from Ointment Base Containing Drug in Suspension. J. Pharm. Sci. 1961; 50: 874–875
- Chandrasekaran S. K., Paul D. R. Dissolution-Controlled Transport from Dispersed Matrices. J. Pharm. Sci. 1982; 71: 1399–1402
- Chang N. J., Himmelstein K. J. Dissolution-Diffusion Controlled Constant-Rate Release from Heterogeneously Loaded Drug-Containing Materials. J. Controlled Release 1990; 12: 201–202
- Jones T. R., White R. A. Topical Formulations of 9-(2-Hydroxyethoxymethyl)guanine. European patent application EP44543, 1982